RetractedArticleOncology letters2020

Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression.

Hongchun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.